Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases

A cost analysis of thiopurine treatment was carried out in 257 patients, with 153 preemptively genotyped for TPMT and 104 retrospectively genotyped in a Spanish setting. The healthcare cost was significantly higher in patients retrospectively genotyped compared to those who were preemptively genotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdez-Acosta, Sarahí, Zubiaur, Pablo, Casado, Miguel Angel, Novalbos, Jesús, Casajús, Ana, Campodónico, Diana, Oyagüez, Itziar, Abad-Santos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455787/
https://www.ncbi.nlm.nih.gov/pubmed/37623459
http://dx.doi.org/10.3390/jpm13081208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455787/
https://www.ncbi.nlm.nih.gov/pubmed/37623459
http://dx.doi.org/10.3390/jpm13081208

Ejemplares similares